What does CUSIP 761330959 represent in this 13F holders report?

CUSIP 761330959 is the security identifier for 761330959 - REVANCE THERAPEUTICS INC - COM - Put used to aggregate holder disclosures.

How many institutions held 761330959 - REVANCE THERAPEUTICS INC - COM - Put in Q2 2022?

No institutional holders were reported for 761330959 - REVANCE THERAPEUTICS INC - COM - Put in Q2 2022; review adjacent reporting periods for trend context.

REVANCE THERAPEUTICS INC - COM - Put

CUSIP: 761330959

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / COM
Price per share: $13.82
Number of holders: 0

Quarterly Holders Quick Answers

What is CUSIP 761330959?
CUSIP 761330959 identifies 761330959 - REVANCE THERAPEUTICS INC - COM - Put in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 761330959:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

REVANCE THERAPEUTICS INC - COM - Put

Q2 2022 13F Holders as of 30 Jun 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of REVANCE THERAPEUTICS INC - COM - Put as of Q2 2022.